FDA Clears Merck’s Keytruda QLEX for Subcutaneous Solid Tumor Use
RAHWAY, N.J. – September 20, 2025 — Merck (NYSE: MRK) announced that the U.S. Food and Drug Administration (FDA)...
Merck
Advertisement
Daiichi Sankyo and Merck Strengthen ADC Pipeline with FDA Nod
BASKING RIDGE, N.J. and RAHWAY, N.J., September 15, 2025 – Daiichi Sankyo and Merck (known as MSD outside the...
Merck’s CAPVAXIVE Shows Strong Immune Response in Children
RAHWAY, N.J. – September 11, 2025 – Merck (NYSE: MRK), known as MSD outside the United States and Canada,...
Advertisement
